Search in:

Advanced search

Acta Cardiologica Volume 76, 2021 - Issue 2

Submit an article Journal homepage

3,541

Views

CrossRef citations to date

Altmetric

Original Scientific Papers

The role of concomitant cardiovascular diseases and cardiac biomarkers for predicting mortality in critical COVID-19 patients

Nesim Aladağa Department of Cardiology, Van Training and Research Hospital, University of Health Sciences, Van, TurkeyCorrespondence[email protected]

https://orcid.org/0000-0003-2346-1152 View further author information

Rukiye Derin Atabeyb Department of Cardiovascular Surgery, Van Training and Research Hospital, University of Health Sciences, Van, Turkey

https://orcid.org/0000-0003-1058-5527 View further author information

Pages 132-139 | Received 19 Jun 2020, Accepted 11 Aug 2020, Published online: 04 Sep 2020

Cite this article
https://doi.org/10.1080/00015385.2020.1810914
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
PubMed Web of Science ®Google Scholar
Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–673.
PubMed Web of Science ®Google Scholar
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
PubMed Web of Science ®Google Scholar
Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011–1019.
PubMed Web of Science ®Google Scholar
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
PubMed Web of Science ®Google Scholar
de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523–534.
PubMed Web of Science ®Google Scholar
Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–393.
PubMed Web of Science ®Google Scholar
Applegate WB, Ouslander JG. COVID-19 presents high risk to older persons. J Am Geriatr Soc. 2020;68(4):681.
PubMed Web of Science ®Google Scholar
Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China. Mech Ageing Dev. 2020;188:111255.
PubMed Web of Science ®Google Scholar
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
PubMed Web of Science ®Google Scholar
Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821–1829.
PubMed Web of Science ®Google Scholar
Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–645.
PubMed Web of Science ®Google Scholar
Sun H, Ning R, Tao Y, et al. Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study. J Am Geriatr Soc. 2020;68(6): E19–E23.
PubMed Web of Science ®Google Scholar
Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524.
PubMed Web of Science ®Google Scholar
Li X, Guan B, Su T, et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 2020;106(15):1142–1147.
PubMed Web of Science ®Google Scholar
Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
PubMed Web of Science ®Google Scholar
Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: is there enough evidence?. J Clin Hypertens. 2020;22(6):943–948.
Web of Science ®Google Scholar
Bhargava A, Fukushima EA, Levine M, et al. Predictors for severe COVID-19 infection. Clin Infect Dis. 2020. [published online ahead of print]. DOI:10.1093/cid/ciaa674
Web of Science ®Google Scholar
Ni M, Tian FB, Xiang DD, et al. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19. J Med Virol. 2020. [published online ahead of print]. DOI:10.1002/jmv.26070
Web of Science ®Google Scholar
Centurión OA, Scavenius KE, García LB, et al. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19. Crit Pathw Cardiol. 2020. [published online ahead of print]. DOI:10.1097/HPC.0000000000000227
Google Scholar
Fan H, Zhang L, Huang B, et al. Cardiac injuries in patients with coronavirus disease 2019: not to be ignored. Int J Infect Dis. 2020;96:294–297.
PubMed Web of Science ®Google Scholar
Kamp TJ, Hamdan MH, January CT. Chloroquine or hydroxychloroquine for COVID-19: is cardiotoxicity a concern? J Am Heart Assoc. 2020;9(12):e016887.
PubMed Web of Science ®Google Scholar
Ma L, Song K, Huang Y. Coronavirus disease-2019 (COVID-19) and cardiovascular complications. J Cardiothorac Vasc Anesth. 2020. [published online ahead of print]. DOI:10.1053/j.jvca.2020.04.041
Web of Science ®Google Scholar
Breakey N, Escher R. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue? Swiss Med Wkly. 2020;150:w20293.
PubMed Web of Science ®Google Scholar
Artifoni M, Danic G, Gautier G, et al. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J Thromb Thrombolysis. 2020;50(1):211–216.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.

Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The role of concomitant cardiovascular diseases and cardiac biomarkers for predicting mortality in critical COVID-19 patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The role of concomitant cardiovascular diseases and cardiac biomarkers for predicting mortality in critical COVID-19 patients

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date